Gautam B, Shrestha B R, Lama P, Rai S
Department of Anaesthesiology and Intensive Care, Kathmandu Medical College, Sinamangal, Nepal.
Kathmandu Univ Med J (KUMJ). 2008 Jul-Sep;6(23):319-28. doi: 10.3126/kumj.v6i3.1706.
Postoperative nausea and vomiting (PONV) is a common distressing experience in patients following laparoscopic surgeries. This study was aimed at comparing the efficacies of Ondansetron-Dexamethasone combination with each drug alone as a prophylaxis against PONV in patients after elective laparoscopic cholecystectomy done under general anaesthesia.
Hundred and fifty ASA I and II patients, aged 23 to 65 yrs, were enrolled in this prospective, randomized, double-blind trial to receive one of three treatment regimens: 4 mg Ondansetron (Group O), 8 mg Dexamethasone (Group D) or 4 mg Ondansetron plus 8 mg Dexamethasone (Group OD) (n=50 for each). A standardized balanced general anaesthetic technique was employed. Any episode of PONV and need for rescue antiemetic were assessed at six, 12 and 24 hrs post operation. Complete response was defined as no PONV in 24 hrs and need for rescue antiemetic was considered as failure of prophylaxis. Pain scores, time to first analgesia demand, amount of Meperidine consumption, adverse event(s) and duration of hospital stay were recorded.
Complete response occurred in 66.7, 66.0 and 89.4% in Groups O, D and OD respectively. Rescue antiemetics were required in 29.2, 31.9 and 8.5% of patients in Groups O, D, and OD respectively. Significantly high incidence of vomiting and failure of prophylaxis (19.1%) occurred in group D during the fi rst six hrs (P=0.023 versus O & 0.008 versus OD). More frequent antiemetic rescue was required in group O at 6 to 24 hr interval as compared to group OD (P=0.032).
Combination of Ondansetron and Dexamethasone is better than each drug alone in preventing PONV after laparoscopic cholecystectomy. Dexamethasone alone is significantly less effective in preventing early vomiting compared to its combination with Ondansetron; whereas Ondansetron alone is less effective against late PONV as compared with combination therapy.
术后恶心呕吐(PONV)是腹腔镜手术后患者常见的痛苦经历。本研究旨在比较昂丹司琼 - 地塞米松联合用药与单独使用每种药物预防全身麻醉下择期腹腔镜胆囊切除术后患者PONV的疗效。
150例年龄在23至65岁的ASA I级和II级患者纳入这项前瞻性、随机、双盲试验,接受三种治疗方案之一:4mg昂丹司琼(O组)、8mg地塞米松(D组)或4mg昂丹司琼加8mg地塞米松(OD组)(每组n = 50)。采用标准化的平衡全身麻醉技术。术后6小时、12小时和24小时评估任何PONV发作情况及使用抢救性止吐药的需求。完全缓解定义为24小时内无PONV,使用抢救性止吐药视为预防失败。记录疼痛评分、首次需要镇痛的时间、哌替啶用量、不良事件及住院时间。
O组、D组和OD组的完全缓解率分别为66.7%、66.0%和89.4%。O组、D组和OD组分别有29.2%、31.9%和8.5%的患者需要使用抢救性止吐药。D组在前6小时呕吐发生率和预防失败率显著较高(19.1%)(与O组相比P = 0.023,与OD组相比P = 0.008)。与OD组相比,O组在6至24小时期间更频繁需要使用抢救性止吐药(P = 0.032)。
腹腔镜胆囊切除术后预防PONV,昂丹司琼和地塞米松联合用药优于单独使用每种药物。单独使用地塞米松预防早期呕吐的效果明显低于其与昂丹司琼联合使用;而单独使用昂丹司琼预防晚期PONV的效果低于联合治疗。